Biogen Newsroom

Wells Fargo Maintains Biogen(BIIB.US) With Hold Rating, Maintains Target Price $225

Futu NewsOct 21 18:34

Biogen Is Maintained at Outperform by BMO Capital

Dow JonesOct 17 22:04

Biogen Analyst Ratings

BenzingaOct 17 21:54

BMO Capital Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $230

Futu NewsOct 17 21:34

Wells Fargo Maintains Biogen(BIIB.US) With Hold Rating, Maintains Target Price $225

Futu NewsOct 15 17:31

Wells Fargo Maintains Biogen(BIIB.US) With Hold Rating, Maintains Target Price $225

Futu NewsOct 12 21:31

Maintaining Hold on Biogen Amid Modest Growth and Cautious Outlook

TipRanksOct 12 21:19

Morgan Stanley Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $285

Futu NewsOct 11 20:31

Raymond James Downgrades Biogen(BIIB.US) to Hold Rating

Futu NewsOct 10 21:31

Biogen Analyst Ratings

BenzingaOct 10 21:03

Analysts Conflicted on These Healthcare Names: Biogen (BIIB) and Traws Pharma (TRAW)

TipRanksOct 9 20:34

J.P. Morgan Maintains Biogen(BIIB.US) With Hold Rating, Announces Target Price $220

Futu NewsOct 9 20:31

UBS lowered Botong's target price to $220.

Gelonghui FinanceOct 9 17:30

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Biogen (BIIB)

TipRanksOct 7 15:32

Barclays Initiates Biogen(BIIB.US) With Hold Rating, Announces Target Price $190

Futu NewsOct 7 15:32

RBC Cuts Price Target on Biogen to $269 From $292, Keeps Outperform Rating

MT NewswiresOct 4 18:32

Biogen Is Maintained at Neutral by UBS

Dow JonesOct 4 03:01

Biogen Analyst Ratings

BenzingaOct 4 02:50

UBS Initiates Biogen(BIIB.US) With Hold Rating, Announces Target Price $202

Futu NewsOct 3 19:31

Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating

Futu NewsOct 1 15:32